Stock Fundamentals

Company Information

Company Name
Century Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US15673T1007
CIK: 0001850119
CUSIP: 15673T100
Currency: USD
Full Time Employees: 78
Phone: 267 817 5790
Fiscal Year End: December
IPO Date: Jun 18, 2021
Description:

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Address:

25 North 38th Street, Philadelphia, PA, United States, 19104

Directors & Officers

Name Title Year Born
Dr. Brent Pfeiffenberger M.B.A., Pharm.D. President, CEO & Chairman 1978
Dr. Gregory Russotti Ph.D. Chief Technology & Manufacturing Officer 1967
Dr. Chad A. Cowan Ph.D. Chief Scientific Officer 1972
Mr. Douglas Carr CPA Senior VP of Finance & Operations, Principal Financial Officer and Secretary NA
Krista Kauppinen J.D., Ph.D. VP, General Counsel & Head of Intellectual Property NA
Ms. Megan Bilson Chief People Officer NA
Michael Naso Ph.D. Senior VP of Cell Engineering NA
Ms. Elizabeth Devlin VP & Head of Development NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 12, 2026 Gregory Russotti N/A Sale 10.08K $2.55 $25.69K
Mar 12, 2026 Douglas Carr N/A Sale 7.04K $2.55 $17.96K
Mar 09, 2026 Gregory Russotti N/A Sale 479.00 $2.54 $1.22K
Feb 03, 2026 Douglas Carr N/A Sale 323.00 $1.82 $587.86
Dec 22, 2025 Chad Cowan N/A Purchase 58.06K $0.85 $49.35K
Dec 12, 2025 Brent Pfeiffenberger N/A Purchase 52.00K $0.58 $30.16K
Dec 08, 2025 Douglas Carr N/A Sale 257.00 $0.53 $136.21
Dec 08, 2025 Gregory Russotti N/A Sale 526.00 $0.53 $278.78
Nov 19, 2025 Brent Pfeiffenberger N/A Purchase 35.00K $0.50 $17.50K
Nov 17, 2025 Brent Pfeiffenberger N/A Sale 32.46K $0.45 $14.61K
Nov 17, 2025 Brent Pfeiffenberger N/A Sale 32.46K $0.45 $14.61K
Nov 03, 2025 Douglas Carr N/A Sale 292.00 $0.59 $172.28
Sep 08, 2025 Brent Pfeiffenberger N/A Sale 488.00 $0.50 $244.00
Sep 08, 2025 Douglas Carr N/A Sale 263.00 $0.50 $131.50
Sep 08, 2025 Gregory Russotti N/A Sale 539.00 $0.50 $269.50
Jun 09, 2025 Adrienne Farid N/A Sale 552.00 $0.62 $342.24
Jun 09, 2025 Brent Pfeiffenberger N/A Sale 475.00 $0.62 $294.50
Jun 09, 2025 Douglas Carr N/A Sale 4.90K $0.62 $3.04K
Jun 09, 2025 Gregory Russotti N/A Sale 526.00 $0.62 $326.12
May 05, 2025 Adrienne Farid N/A Sale 1.02K $0.55 $563.20

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 17.75M Mar 31, 2026 9.84% $0.43 0.00%
TCG Crossover Management, LLC 17.75M Mar 31, 2026 9.84% $1.12 0.00%
Versant Venture Management LLC 12.17M Mar 31, 2026 6.75% $19.44 0.00%
Deep Track Capital, LP 9.49M Mar 31, 2026 5.26% $0.35 0.00%
VR Adviser, LLC 8.70M Mar 31, 2026 4.82% $0.73 0.00%
COMMODORE CAPITAL LP 8.70M Mar 31, 2026 4.82% $1.14 0.00%
RTW INVESTMENTS, LLC 8.70M Mar 31, 2026 4.82% $0.20 0.00%
Point72 Asset Management, L.P. 5.96M Mar 31, 2026 3.31% $0.02 0.05%
Vanguard Capital Management, LLC 5.69M Mar 31, 2026 3.15% $0.00 0.00%
Balyasny Asset Management LLC 5.02M Mar 31, 2026 2.78% $0.01 0.00%
Millennium Management LLC 4.67M Mar 31, 2026 2.59% $0.00 664.61%
Spruce Street Capital LP 4.06M Mar 31, 2026 2.25% $2.21 185.54%
Adage Capital Partners Gp LLC 3.79M Mar 31, 2026 2.10% $0.01 106.10%
Woodline Partners LP 3.04M Mar 31, 2026 1.69% $0.03 0.00%
Seven Fleet Capital Management LP 2.95M Mar 31, 2026 1.63% $2.11 0.00%
Trails Edge Capital Partners, LP 2.45M Mar 31, 2026 1.36% $1.27 0.00%
Dafna Capital Management LLC 2.43M Mar 31, 2026 1.35% $1.25 -12.86%
Two Sigma Investments LLC 2.37M Mar 31, 2026 1.31% $0.00 58.53%
Vanguard Group Inc 2.10M Dec 31, 2025 1.17% $0.00 0.00%
BlackRock Inc 1.52M Mar 31, 2026 0.85% $0.00 153.28%

Shares Statistics

Shares Outstanding: 180.35M
Shares Float: 97.85M
% Insiders: 1,206.60%
% Institutions: 7,846.20%
Short % Float: 6.96%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 4.34M 2.41% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 1.21M 0.67% ▲ 0.00% Apr 30, 2026
3 Fidelity Extended Market Index 575.60K 0.32% ▼ 0.36% Apr 30, 2026
4 Blackrock Extended Mkt Fund CF 291.85K 0.16% ▲ 0.00% Apr 30, 2026
5 BlackRock Extended Equity Market Fund K 248.50K 0.14% ▲ 151.20% Mar 31, 2026
6 Fidelity Total Market Index 200.45K 0.11% ▲ 0.00% Apr 30, 2026
7 Fidelity Series Total Market Index 164.28K 0.09% ▲ 0.00% Apr 30, 2026
8 Spartan Extended Market Index Pool F 153.10K 0.08% ▲ 1.39% Apr 30, 2026
9 NT Ext Equity Mkt Index Fund - Lending 130.05K 0.07% ▲ 53.49% Mar 31, 2026
10 Northern Trust Extended Eq Market Idx 130.05K 0.07% ▲ 178.62% Mar 31, 2026

Valuation Metrics

Enterprise Value: $319.02M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $405.80M
EBITDA: $-101.60M
Book Value: $1.47
Earnings/Share: $-1.14
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -22.28%
ROE (TTM): -42.67%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.97x 0.02x 0.29x N/A 0.96x
2024-12-31 1.50x 0.03x 0.54x N/A -0.04x
2023-12-31 9.92x 0.01x 0.49x -271.38x -0.01x
2022-12-31 10.72x 0.04x 0.38x -121.11x -0.09x
2021-12-31 14.57x 0.03x 0.09x -74.42x -0.12x
2020-12-31 6.51x -0.09x 2.00x -129.07x -0.19x
2019-12-31 28.10x 0.00x 2.01x N/A 0.00x
2016-12-31 0.00x 1.51x 0.76x N/A N/A
2015-12-31 0.00x 0.43x 0.57x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IPSC.US!